RETATRUTIDE VS. TIRZEPATIDE : A HEAD-TO-HEAD EVALUATION

Both retatrutide and the currently available drug represent significant breakthroughs in metabolic disorder treatment, but their mechanisms of action and initial clinical findings present key differences . Retatrutide functions as a dual GIP and GLP-1 target agonist, while tirzepatide also acts o